Clinical Trials in North Dakota (ND) | North Dakota Clinical Drug Trials & Studies

You are viewing Clinical Trials In North Dakota

Have multiple conditions? Click here

Showing 1-100 of 439

There are 439 trials in North Dakota

Name	City	State	Zip
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Minot	ND	58701
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Minot	ND	58701
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Minot	ND	58701
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer	Minot	ND	58701
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Minot	ND	58701
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	Minot	ND	58701
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy	Minot	ND	58701
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials	Minot	ND	58701
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer	Minot	ND	58701
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Minot	ND	58701
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels	Minot	ND	58701
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Minot	ND	58701
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Minot	ND	58701
Safety Study of Membrane Sweeping in Pregnancy	Minot	ND	58701
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor	Minot	ND	58701
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Minot	ND	58701
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	Minot	ND	58701
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Minot	ND	58701
Comparison of Body and Room Temperature Saline in Urodynamics	Minot	ND	58701
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Minot	ND	58701
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy	Minot	ND	58701
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Minot	ND	58701
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Minot	ND	58701
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery	Minot	ND	58701
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer	Minot	ND	58701
Acute Pain Caused by Paclitaxel in Patients With Cancer	Minot	ND	58701
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Minot	ND	58701
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients	Minot	ND	58701
Cortisol Response to Moderate and Deep Sedation in Children	Minot	ND	58701
Study of Kidney Tumors in Young Patients	Minot	ND	58701
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Minot	ND	58701
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Minot	ND	58701
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer	Minot	ND	58701
Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies	Minot	ND	58701
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers	Minot	ND	58701
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery	Minot	ND	58701
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy	Minot	ND	58701
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Minot	ND	58701
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Minot	ND	58701
Evaluation Of New Onset Postoperative Atrial Fibrillation	Minot	ND	58701
Athena Pelvic Muscle Trainer - DUETS Trial	Minot	ND	58703
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy	Minot	ND	58701
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer	Grand Forks	ND	58201
Insulin Resistance Intervention After Stroke Trial	Grand Forks	ND	58201
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Grand Forks	ND	58201
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Grand Forks	ND	58201
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma	Grand Forks	ND	58201
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy	Grand Forks	ND	58201
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Grand Forks	ND	58201
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer	Grand Forks	ND	58201
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Grand Forks	ND	58201
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Grand Forks	ND	58201
Acute Pain Caused by Paclitaxel in Patients With Cancer	Grand Forks	ND	58201
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Grand Forks	ND	58201
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Grand Forks	ND	58201
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction	Grand Forks	ND	58201
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma	Grand Forks	ND	58201
The Dual Antiplatelet Therapy Study (DAPT Study)	Grand Forks	ND	58201
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	Grand Forks	ND	58201
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants	Grand Forks	ND	58201
Home-Based Programs for Improving Sleep in Cancer Survivors	Grand Forks	ND	58201
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy	Grand Forks	ND	58201
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Grand Forks	ND	58201
Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency	Grand Forks	ND	58202
Effect of High Omega-3 Fish Intake on Lipid Peroxidation	Grand Forks	ND	58202
Healthy Creations: Community Based Lifestyle Intervention Validation	Grand Forks	ND	58202
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.	Grand Forks	ND
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer	Grand Forks	ND	58203
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Fargo	ND	58122
Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia	Fargo	ND	58122
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Fargo	ND	58122
Study of Late-Occurring Complications in Childhood Cancer Survivors	Fargo	ND	58122
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Fargo	ND	58122
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer	Fargo	ND	58122
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer	Fargo	ND	58122
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer	Fargo	ND	58122
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia	Fargo	ND	58122
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Fargo	ND	58122
Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma	Fargo	ND	58122
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	Fargo	ND	58122
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Fargo	ND	58122
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Fargo	ND	58122
VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer	Fargo	ND	58122
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes	Fargo	ND	58122
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection	Fargo	ND	58122
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Fargo	ND	58122
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Fargo	ND	58122
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Fargo	ND	58122
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Fargo	ND	58122
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Fargo	ND	58122
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies	Fargo	ND	58122
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Fargo	ND	58122
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Fargo	ND	58122
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Fargo	ND	58122
Acute Pain Caused by Paclitaxel in Patients With Cancer	Fargo	ND	58122
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer	Fargo	ND	58122
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Fargo	ND	58122
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme	Fargo	ND	58122
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Fargo	ND	58122
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Fargo	ND	58122

View Clinical Trial Facilities in North Dakota

Showing 1-100 of 439